Associated Papers
Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions.
Josephs KS et al.
Genome Medicine, 2023
Beyond gene-disease validity: capturing structured data on inheritance, allelic-requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions.
Josephs KS et al.
Medrxiv : the Preprint Server for Health Sciences, 2023
New insights provided by myofibril mechanics in inherited cardiomyopathies.
Lin YH et al.
Conditioning Medicine, 2019
[Genetic testing to prevent sudden cardiac death].
Stallmeyer B et al.
Der Internist, 2018
Late Gadolinium Enhancement for Prediction of Mutation-Positive Hypertrophic Cardiomyopathy on the Basis of Panel-Wide Sequencing.
Teramoto R et al.
Circulation Journal : Official Journal of the Japanese Circulation Society, 2018
Cardiomyopathies with Mixed and Inapparent Morphological Features in Cardiac Troponin I3 Mutation.
Sohn DW et al.
Korean Circulation Journal, 2017
A Systematic Review of Phenotypic Features Associated With Cardiac Troponin I Mutations in Hereditary Cardiomyopathies.
Mogensen J et al.
The Canadian Journal of Cardiology, 2015
Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
Nomura A et al.
Circulation Journal : Official Journal of the Japanese Circulation Society, 2015
Impact of systolic dysfunction in genotyped hypertrophic cardiomyopathy.
Fujino N et al.
Clinical Cardiology, 2013
VIP gene deletion in mice causes cardiomyopathy associated with upregulation of heart failure genes.
Szema AM et al.
Plos One, 2013
[Clinical and genetic aspects of hypertrophic and dilated cardiomyopathy].
Meder B et al.
Der Internist, 2012
Impact of renin-angiotensin system polymorphisms on development of systolic dysfunction in hypertrophic cardiomyopathy. Evidence from a study of genotyped patients.
Funada A et al.
Circulation Journal : Official Journal of the Japanese Circulation Society, 2010
Heterogeneity of clinical manifestation of hypertrophic cardiomyopathy caused by deletion of lysine 183 in cardiac troponin I gene.
Funada A et al.
International Heart Journal, 2010
Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy.
Uchiyama K et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2009
Exercise-induced systolic dysfunction in patients with non-obstructive hypertrophic cardiomyopathy and mutations in the cardiac troponin genes.
Sakata K et al.
Heart (british Cardiac Society), 2008
Gender-specific clinical characteristics of deep Q waves in hypertrophic cardiomyopathy.
Ohmoto-Sekine Y et al.
Gender Medicine, 2007
Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis.
Konno T et al.
Clinical Science (london, England : 1979), 2007
Hypertrophic cardiomyopathy: electrocardiographic manifestations and other important considerations for the emergency physician.
Kelly BS et al.
The American Journal of Emergency Medicine, 2007
Troponin mutations in cardiomyopathies.
Mogensen J
Advances in Experimental Medicine and Biology, 2007
Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population.
Konno T et al.
The American Journal of Cardiology, 2005
Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects.
Konno T et al.
Journal of Internal Medicine, 2005
Genetic causes of human heart failure.
Morita H et al.
The Journal of Clinical Investigation, 2005
Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
Mogensen J et al.
Journal of the American College of Cardiology, 2004
What is the value of mutation identification in familial hypertrophic cardiomyopathy?
Yu B
Iubmb Life, 2004
Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis.
Konno T et al.
European Heart Journal, 2004
T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion.
Shimizu M et al.
Clinical Cardiology, 2002
Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation.
Shimizu M et al.
American Heart Journal, 2002
Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin 1 mutation.
Shimizu M et al.
American Heart Journal, 2002
Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy.
James J et al.
Circulation Research, 2000
Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.
Kokado H et al.
Circulation, 2000
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.
Kimura A et al.
Nature Genetics, 1997